Insulin resistance, hyperglycemia, and atherosclerosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22055501.
- Also identified by DOI 10.1016/j.cmet.2011.07.015 and PMC identifier 3217209.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Progress in preventing atherosclerotic coronary artery disease (CAD) has been stalled by the epidemic of type 2 diabetes. Further advances in this area demand a thorough understanding of how two major features of type 2 diabetes, insulin resistance and hyperglycemia, impact atherosclerosis. Insulin resistance is associated with systemic CAD risk factors, but increasing evidence suggests that defective insulin signaling in atherosclerotic lesional cells also plays an important role. The role of hyperglycemia in CAD associated with type 2 diabetes is less clear. Understanding the mechanisms whereby type 2 diabetes exacerbates CAD offers hope for new therapeutic strategies to prevent and treat atherosclerotic vascular disease.
Medical subject headings
- Atherosclerosis
- Coronary Artery Disease
- Diabetes Mellitus, Type 2
- Hyperglycemia
- Insulin
- Insulin Resistance
- Signal Transduction